Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis

Journal of Autoimmunity

Volumn 34, Issue 3, 2010, Pages

  Chandran, Vinod ^a   Raychaudhuri, Siba P ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

Autoimmunity; Epidemiology; Genetics; Incidence; Prevalence; Psoriasis; Psoriatic arthritis

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; INTERLEUKIN 12P40; INTERLEUKIN 21; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 4;

ARTICLE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENE LOCUS; GENETIC RISK; GENOME ANALYSIS; GEOGRAPHY; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; OBESITY; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; STREPTOCOCCAL PHARYNGITIS;

ANIMALS; ARTHRITIS, PSORIATIC; CLIMATE; DIET; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HLA-C ANTIGENS; HUMANS; INCIDENCE; INFECTION; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS; STRESS, PHYSIOLOGICAL; UNITED STATES;

EID: 77649186719     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.12.001     Document Type: Article

References (98)

1. Raychaudhuri S.P., and Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 17 (2000) 174-178
2. Nestle F.O., Kaplan D.H., and Barker J. Psoriasis. N Engl J Med 361 (2009) 496-509
3. Gelfand J.M., Troxel A.B., Lewis J.D., Kurd S.K., Shin D.B., Wang X., et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 143 (2007) 1493-1499
4. Turkiewicz A.M., and Moreland L.W. Psoriatic arthritis: current concepts on pathogenesis-oriented therapeutic options. Arthritis Rheum 56 (2007) 1051-1066
5. Reich K., Krüger K., Mössner R., and Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160 (2009) 1040-1047
6. Gladman D.D., Farewell V.T., Wong K., and Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 41 (1998) 1103-1110
7. Raychaudhuri S.P., and Farber E.M. The prevalence of psoriasis in the world. J Eur Acad Dermatol Venereol 15 (2001) 16-17
8. Farber E.M., and Nall L. Epidemiology: natural history and genetics. In: Roenigk Jr. H.H., and Maibach H.I. (Eds). Psoriasis (1998), Dekker, New York 107-157
9. Lomholt G. Psoriasis: prevalence, spontaneous course and genetics: a census study on the prevalence of skin diseases on the Faroe Islands (1963), GEC Gad, Copenhagen
10. Gudjonsson J.E., and Elder J.T. Psoriasis: epidemiology. Clin Dermatol 25 (2007) 535-546
11. Olsen A.O., Grjibovski A., Magnus P., Tambs K., and Harris J.R. Psoriasis in Norway as observed in a population-based Norwegian twin panel. Br J Dermatol 153 (2005) 346-351
12. Nevitt G.J., and Hutchinson P.E. Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease. Br J Dermatol 135 (1996) 533-537
13. Gelfand J.M., Weinstein R., Porter S.B., Neimann A.L., Berlin J.A., and Margolis D.J. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 141 (2005) 1537-1541
14. Ibrahim G., Waxman R., and Helliwell P.S. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum 61 (2009) 1373-1378
15. Schäfer T. Epidemiology of psoriasis. Review and the German perspective. Dermatology 212 (2006) 327-337
16. Naldi L., Colombo P., Placchesi E.B., Piccitto R., Chatenoud L., La Vecchia C., et al. Study design and preliminary results from the pilot phase of the PraKtis study: self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology 208 (2004) 38-42
17. Saraceno R., Mannheimer R., and Chimenti S. Regional distribution of psoriasis in Italy. J Eur Acad Dermatol Venereol 22 (2008) 324-329
18. Wolkenstein P., Grob J.J., Bastuji-Garin S., Ruszczynski S., Roujeau J.C., Revuz J., et al. French people and skin diseases: results of a survey using a representative sample. Arch Dermatol 139 (2003) 1614-1619 discussion 1619
19. Wolkenstein P., Revuz J., Roujeau J.C., Bonnelye G., Grob J.J., Bastuji-Garin S., et al. Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. Dermatology 218 (2009) 103-109
20. Ferrándiz C., Bordas X., García-Patos V., Puig S., Pujol R., and Smandía A. Prevalence of psoriasis in Spain (Epiderma Project: phase I). J Eur Acad Dermatol Venereol 15 (2001) 20-23
21. Stern R.S., Nijsten T., Feldman S.R., Margolis D.J., and Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9 (2004) 136-139
22. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 14 (1996) 485-496
23. Kurd S.K., and Gelfand J.M. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol 60 (2009) 218-224 Erratum in: J Am Acad Dermatol 2009;61:507
24. Gelfand J.M., Stern R.S., Nijsten T., Feldman S.R., Thomas J., Kist J., et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 52 (2005) 23-26
25. Nall L., Gulliver W., Charmley P., and Farber E.M. Search for the psoriasis susceptibility gene: the Newfoundland Study. Cutis 64 (1999) 323-329
26. Ogunbiyi A.O., Daramola O.O., and Alese O.O. Prevalence of skin diseases in Ibadan, Nigeria. Int J Dermatol 43 (2004) 31-36
27. Doe P.T., Asiedu A., and Acheampong J.W. Rowland Payne CM. Skin diseases in Ghana and the UK. Int J Dermatol 40 (2001) 323-326
28. Farber E.M., and Nall L. Psoriasis in the tropics. Epidemiologic, genetic, clinical, and therapeutic aspects. Dermatol Clin 12 (1994) 805-816
29. Suite M. The epidemiology of psoriasis in a dermatology clinic in a general hospital in Port-of-Spain, Trinidad and Tobago, West Indies. West Indian Med J 55 (2006) 399-402
30. Minaur N., Sawyers S., Parker J., and Darmawan J. Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey. J Rheumatol 31 (2004) 965-972
31. Plunkett A., and Marks R. A review of the epidemiology of psoriasis vulgaris in the community. Australas J Dermatol 39 (1998) 225-232
32. Lin X.R. Psoriasis in China. J Dermatol 20 (1993) 746-755
33. Chang Y.T., Chen T.J., Liu P.C., Chen Y.C., Chen Y.J., Huang Y.L., et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan. Acta Derm Venereol 89 (2009) 262-266
34. Kaur I., Handa S., and Kumar B. Natural history of psoriasis: a study from the Indian subcontinent. J Dermatol 24 (1997) 230-234
35. Fatani M.I., Abdulghani M.H., and Al-Afif K.A. Psoriasis in the eastern Saudi Arabia. Saudi Med J 23 (2002) 213-217
36. Shelleh H.H., and Al-Hatiti H.S. Pattern of skin diseases in a hospital in southwestern Saudi Arabia. Saudi Med J 25 (2004) 507-510
37. Alakloby O.M. Pattern of skin diseases in Eastern Saudi Arabia. Saudi Med J 26 (2005) 1607-1610
38. Icen M., Crowson C.S., McEvoy M.T., Dann F.J., Gabriel S.E., and Maradit Kremers H. Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol 60 (2009) 394-401
39. Huerta C., Rivero E., and Rodríguez L.A. Incidence and risk factors for psoriasis in the general population. Arch Dermatol 143 (2007) 1559-1565
40. Marsh S.G.E., Parham P., and Barber L.D. Cw*06 - Cw6. The HLA facts book (2000), Academic Press, London 255-256
41. Alamanos Y., Voulgari P.V., and Drosos A.A. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 35 (2008) 1354-1358
42. Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H., et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54 (2006) 2665-2673
43. Chandran V., Schentag C.T., and Gladman D.D. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 57 (2007) 1560-1563
44. O'Neill T., and Silman A.J. Psoriatic arthritis. Historical background and epidemiology. Baillieres Clin Rheumatol 8 (1994) 245-261
45. Saraux A., Guillemin F., Guggenbuhl P., Roux C.H., Fardellone P., Le Bihan E., et al. Prevalence of spondyloarthropathies in France. Ann Rheum Dis 2005 64 (2001) 1431-1435
46. Alamanos Y., Papadopoulos N.G., Voulgari P.V., Siozos C., Psychos D.N., Tympanidou M., et al. Epidemiology of psoriatic arthritis in northwest Greece, 1982-2001. J Rheumatol 30 (2003) 2641-2644
47. Trontzas P., Andrianakos A., Miyakis S., Pantelidou K., Vafiadou E., Garantziotou V., et al. Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol 24 (2005) 583-589
48. Madland T.M., Apalset E.M., Johannessen A.E., Rossebö B., and Brun J.G. Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 32 (2005) 1918-1922
49. Love T.J., Gudbjornsson B., Gudjonsson J.E., and Valdimarsson H. Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course. J Rheumatol 34 (2007) 2082-2088
50. Pedersen O.B., Svendsen A.J., Ejstrup L., Skytthe A., and Junker P. The occurrence of psoriatic arthritis in Denmark. Ann Rheum Dis 67 (2008) 1422-1426
51. De Angelis R., Salaffi F., and Grassi W. Prevalence of spondyloarthropathies in an Italian population sample: a regional community-based study. Scand J Rheumatol 36 (2007) 14-21
52. Shbeeb M., Uramoto K.M., Gibson L.E., O'Fallon W.M., and Gabriel S.E. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol 27 (2000) 1247-1250
53. Wilson F.C., Icen M., Crowson C.S., McEvoy M.T., Gabriel S.E., and Kremers H.M. Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study. J Rheumatol 36 (2009) 361-367
54. Gelfand J.M., Gladman D.D., Mease P.J., Smith N., Margolis D.J., Nijsten T., et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53 (2005) 573-577
55. Hukuda S., Minami M., Saito T., Mitsui H., Matsui N., Komatsubara Y., et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol 28 (2001) 554-559
56. Zeng Q.Y., Chen R., Darmawan J., Xiao Z.Y., Chen S.B., Wigley R., et al. Rheumatic diseases in China. Arthritis Res Ther 10 (2008) R17
57. Gladman D.D. Clinical, radiological, and functional assessment in psoriatic arthritis: is it different from other inflammatory joint diseases?. Ann Rheum Dis 65 Suppl. 3 (2006) iii22-iii24
58. Wilson F.C., Icen M., Crowson C.S., McEvoy M.T., Gabriel S.E., and Kremers H.M. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 61 (2009) 233-239
59. Gladman D.D., Antoni C., Mease P., Clegg D.O., and Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64 Suppl. 2 (2005) ii14-ii17
60. Gisondi P., Girolomoni G., Sampogna F., Tabolli S., and Abeni D. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol 15 (2005) 279-283
61. Scarpa R., Oriente P., Pucino A., Torella M., Vignone L., Riccio A., et al. Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23 (1984) 246-250
62. Salvarani C., Lo Scocco G., Macchioni P., Cremonesi T., Rossi F., Mantovani W., et al. Prevalence of psoriatic arthritis in Italian psoriatic patients. J Rheumatol 22 (1995) 1499-1503
63. Alenius G.M., Stenberg B., Stenlund H., Lundblad M., and Dahlqvist S.R. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire. J Rheumatol 29 (2002) 2577-2582
64. Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 4 (2003) 441-447
65. Radtke M.A., Reich K., Blome C., Rustenbach S., and Augustin M. Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 23 (2009) 683-691
66. Christophers E, Barker J, Griffiths C, Daudén E, Milligan G, Molta C, et al. The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics. J Eur Acad Dermatol Venereol. Published online 2009 Oct 23. PubMed PMID: 19874432.
67. Jajić Z., and el Assadi G. Prevalence of psoriatic arthritis in a population of patients with psoriasis. Acta Med Croatica 57 (2003) 323-326
68. Jamshidi F., Bouzari N., Seirafi H., Farnaghi F., and Firooz A. Arch Iran Med 11 (2008) 162-165
69. Kawada A., Tezuka T., Nakamizo Y., Kimura H., Nakagawa H., Ohkido M., et al. A survey of psoriasis patients in Japan from 1982 to 2001. J Dermatol Sci 31 (2003) 59-64
70. Kaipiainen-Seppänen O. Incidence of psoriatic arthritis in Finland. Br J Rheumatol 35 (1996) 1289-1291
71. Savolainen E., Kaipiainen-Seppänen O., Kröger L., and Luosujärvi R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 30 (2003) 2460-2468
72. Söderlin M.K., Börjesson O., Kautiainen H., Skogh T., and Leirisalo-Repo M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 61 (2002) 911-915
73. Rahman P., and Elder J.T. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 64 Suppl. 2 (2005) ii37-ii39 discussion ii40-ii41
74. Chandran V., Schentag C.T., Brockbank J.E., Pellett F.J., Shanmugarajah S., Toloza S.M., et al. Familial aggregation of psoriatic arthritis. Ann Rheum Dis 68 (2009) 664-667
75. Karason A., Love T.J., and Gudbjornsson B. A strong heritability of psoriatic arthritis over four generations - the Reykjavik Psoriatic Arthritis Study. Rheumatology (Oxford) 48 (2009) 1424-1428
76. Pedersen O.B., Svendsen A.J., Ejstrup L., Skytthe A., and Junker P. On the heritability of psoriatic arthritis. Disease concordance among monozygotic and dizygotic twins. Ann Rheum Dis 67 (2008) 1417-1421
77. Duffin K.C., Chandran V., Gladman D.D., Krueger G.G., Elder J.T., and Rahman P. Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol 35 (2008) 1449-1453
78. Ho P.Y., Barton A., Worthington J., Thomson W., Silman A.J., and Bruce I.N. HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis 66 (2007) 807-811
79. Nair R.P., Stuart P.E., Nistor I., Hiremagalore R., Chia N.V., Jenisch S., et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet 78 (2006) 827-851
80. Rahman P., Roslin N.M., Pellett F., Paterson A., Beyene J., Lemire M., et al. High-resolution association mapping in the MHC region identifies multiple independent loci for psoriatic arthritis. Arthritis Rheum 60 (2009) S536
81. Cargill M., Schrodi S.J., Chang M., Garcia V.E., Brandon R., Callis K.P., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80 (2007) 273-290
82. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41 (2009) 199-204
83. Zhang X.J., Huang W., Yang S., Sun L.D., Zhang F.Y., Zhu Q.X., et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet 41 (2009) 205-210
84. Rahman P., Inman R.D., Maksymowych W.P., Reeve J.P., Peddle L., and Gladman D.D. Association of interleukin 23 receptor variants with psoriatic arthritis. J Rheumatol 36 (2009) 137-140
85. Liu Y., Helms C., Liao W., Zaba L.C., Duan S., Gardner J., et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 4 (2008) e1000041
86. Hollox E.J., Huffmeier U., Zeeuwen P.L., Palla R., Lascorz J., Rodijk-Olthuis D., et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet 40 (2008) 23-25
87. de Cid R., Riveira-Munoz E., Zeeuwen P.L., Robarge J., Liao W., Dannhauser E.N., et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 41 (2009) 211-215
88. Hüffmeier U, Estivill X, Riveira-Munoz E, Traupe H, Wendler J, Lohmann J, et al. Deletion of LCE3C and LCE3B genes at PSORS4 does not contribute to Susceptibility to Psoriatic Arthritis in German patients. Ann Rheum Dis. Published online 2009 May 12. 19439430.
89. Gudjonsson J.E., Thorarinsson A.M., Sigurgeirsson B., Kristinsson K.G., and Valdimarssonn H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 149 (2003) 530-534
90. Gudjonsson J.E., Karason A., Runarsdottir E.H., Antonsdottir A.A., Hauksson V.B., Jónsson H.H., et al. Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C- and HLA-B-typed patients. J Invest Dermatol 126 (2006) 740-745
91. Patel R.V., and Weinberg J.M. Psoriasis in the patient with human immunodeficiency virus, part 1: review of pathogenesis. Cutis 82 (2008) 117-122
92. Jin Y., Yang S., Zhang F., Kong Y., Xiao F., Hou Y., et al. Combined effects of HLA-Cw6 and cigarette smoking in psoriasis vulgaris: a hospital-based case-control study in China. J Eur Acad Dermatol Venereol 23 (2009) 132-137
93. Setty A.R., Curhan G., and Choi H.K. Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 120 (2007) 953-959
94. Raychaudhuri S.P., and Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis 66 (2000) 348-352
95. Pattison E., Harrison B.J., Griffiths C.E., Silman A.J., and Bruce I.N. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 67 (2008) 672-676
96. Reveille J.D., and Williams F.M. Infection and musculoskeletal conditions: rheumatologic complications of HIV infection. Best Pract Res Clin Rheumatol 20 (2006) 1159-1179
97. Rakkhit T., Wong B., Nelson T.S., Hansen C.B., Papenfuss J.S., Panko J., et al. Time to development of psoriatic arthritis decreases with smoking prior to psoriasis onset and increases with smoking after psoriasis onset. J Invest Dermatol 127 Suppl. 1 (2007) S52
98. Duffin K.C., Freeny I.C., Schrodi S.J., Wong B., Feng B.J., Soltani-Arabshahi R., et al. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol 129 (2009) 2777-2783